pubmed-article:9230191 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9230191 | lifeskim:mentions | umls-concept:C0020971 | lld:lifeskim |
pubmed-article:9230191 | lifeskim:mentions | umls-concept:C0025202 | lld:lifeskim |
pubmed-article:9230191 | lifeskim:mentions | umls-concept:C0011306 | lld:lifeskim |
pubmed-article:9230191 | lifeskim:mentions | umls-concept:C0003320 | lld:lifeskim |
pubmed-article:9230191 | lifeskim:mentions | umls-concept:C1334510 | lld:lifeskim |
pubmed-article:9230191 | lifeskim:mentions | umls-concept:C0314603 | lld:lifeskim |
pubmed-article:9230191 | lifeskim:mentions | umls-concept:C0385723 | lld:lifeskim |
pubmed-article:9230191 | lifeskim:mentions | umls-concept:C0591833 | lld:lifeskim |
pubmed-article:9230191 | pubmed:issue | 14 | lld:pubmed |
pubmed-article:9230191 | pubmed:dateCreated | 1997-8-7 | lld:pubmed |
pubmed-article:9230191 | pubmed:abstractText | Dendritic cells (DCs) are professional antigen-presenting cells that process and present antigenic peptides and are capable of generating potent T-cell immunity. A murine tumor model was developed to evaluate methods of genetic immunization to the human MART-1/Melan-A (MART-1) melanoma antigen. A poorly immunogenic murine fibrosarcoma line (NFSA) was stably transfected with the MART-1 gene. This transfected tumor [NFSA(MART1)] grows progressively in C3Hf/Kam/Sed (H-2k) mice. Partial protection against a challenge with NFSA(MART1) could be achieved with i.m. injections of a MART-1 expression plasmid or with systemic administration of an adenovirus vector expressing MART-1. However, superior protection was achieved when granulocyte macrophage colony-stimulating factor/interleukin-4-differentiated murine DCs transduced with an adenovirus vector expressing MART-1 were used for immunization. Both partial and complete protection could be achieved with i.v. administration of MART-1-engineered DCs. Splenocytes from immunized mice contained MHC class 1-restricted CTLs specific for MART-1. This preclinical model of genetic immunization supports a therapeutic strategy for human melanoma. | lld:pubmed |
pubmed-article:9230191 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9230191 | pubmed:language | eng | lld:pubmed |
pubmed-article:9230191 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9230191 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9230191 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9230191 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9230191 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9230191 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9230191 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9230191 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9230191 | pubmed:month | Jul | lld:pubmed |
pubmed-article:9230191 | pubmed:issn | 0008-5472 | lld:pubmed |
pubmed-article:9230191 | pubmed:author | pubmed-author:EconomouJ SJS | lld:pubmed |
pubmed-article:9230191 | pubmed:author | pubmed-author:McBrideW HWH | lld:pubmed |
pubmed-article:9230191 | pubmed:author | pubmed-author:LawPP | lld:pubmed |
pubmed-article:9230191 | pubmed:author | pubmed-author:LawG RGR | lld:pubmed |
pubmed-article:9230191 | pubmed:author | pubmed-author:ElyJ SJS | lld:pubmed |
pubmed-article:9230191 | pubmed:author | pubmed-author:RibasAA | lld:pubmed |
pubmed-article:9230191 | pubmed:author | pubmed-author:VollmerC MCM | lld:pubmed |
pubmed-article:9230191 | pubmed:author | pubmed-author:GlaspyJ AJA | lld:pubmed |
pubmed-article:9230191 | pubmed:author | pubmed-author:ChenA YAY | lld:pubmed |
pubmed-article:9230191 | pubmed:author | pubmed-author:DissetteV BVB | lld:pubmed |
pubmed-article:9230191 | pubmed:author | pubmed-author:ButterfieldL... | lld:pubmed |
pubmed-article:9230191 | pubmed:author | pubmed-author:JilaniS MSM | lld:pubmed |
pubmed-article:9230191 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9230191 | pubmed:day | 15 | lld:pubmed |
pubmed-article:9230191 | pubmed:volume | 57 | lld:pubmed |
pubmed-article:9230191 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9230191 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9230191 | pubmed:pagination | 2865-9 | lld:pubmed |
pubmed-article:9230191 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:9230191 | pubmed:meshHeading | pubmed-meshheading:9230191-... | lld:pubmed |
pubmed-article:9230191 | pubmed:meshHeading | pubmed-meshheading:9230191-... | lld:pubmed |
pubmed-article:9230191 | pubmed:meshHeading | pubmed-meshheading:9230191-... | lld:pubmed |
pubmed-article:9230191 | pubmed:meshHeading | pubmed-meshheading:9230191-... | lld:pubmed |
pubmed-article:9230191 | pubmed:meshHeading | pubmed-meshheading:9230191-... | lld:pubmed |
pubmed-article:9230191 | pubmed:meshHeading | pubmed-meshheading:9230191-... | lld:pubmed |
pubmed-article:9230191 | pubmed:meshHeading | pubmed-meshheading:9230191-... | lld:pubmed |
pubmed-article:9230191 | pubmed:meshHeading | pubmed-meshheading:9230191-... | lld:pubmed |
pubmed-article:9230191 | pubmed:meshHeading | pubmed-meshheading:9230191-... | lld:pubmed |
pubmed-article:9230191 | pubmed:meshHeading | pubmed-meshheading:9230191-... | lld:pubmed |
pubmed-article:9230191 | pubmed:meshHeading | pubmed-meshheading:9230191-... | lld:pubmed |
pubmed-article:9230191 | pubmed:meshHeading | pubmed-meshheading:9230191-... | lld:pubmed |
pubmed-article:9230191 | pubmed:meshHeading | pubmed-meshheading:9230191-... | lld:pubmed |
pubmed-article:9230191 | pubmed:meshHeading | pubmed-meshheading:9230191-... | lld:pubmed |
pubmed-article:9230191 | pubmed:year | 1997 | lld:pubmed |
pubmed-article:9230191 | pubmed:articleTitle | Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells. | lld:pubmed |
pubmed-article:9230191 | pubmed:affiliation | Division of Surgical Oncology, University of California Los Angeles Medical Center, 90024, USA. | lld:pubmed |
pubmed-article:9230191 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9230191 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:9230191 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9230191 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9230191 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9230191 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9230191 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9230191 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9230191 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9230191 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9230191 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9230191 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9230191 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9230191 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9230191 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9230191 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9230191 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9230191 | lld:pubmed |